VERACYTE, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
VERACYTE, INC. (VCYT) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $6.46 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $6.46M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $9.39M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $3.33M.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $6.66M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $6.46M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $9.39M 10-Q · filed 2026-05-06 |
| 2025-09-30 | $3.33M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $6.66M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $9.62M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $3.77M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $7.53M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $11.33M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $4.52M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $10.68M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $16.04M 10-Q · filed 2023-05-05 |
| 2022-09-30 | $5.18M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $10.56M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $16.43M 10-Q · filed 2022-05-04 |
| 2021-09-30 | $5.54M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $7.45M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $11.13M 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |